Enzo CEO: Clinical Business Heating Up, Patents Wins Will Continue - Presented by: The Aol. On Network

Shares of Enzo Biochem have been flying over the past year due to increased demand for its clinical products, successful patent resolutions and new product introductions, says the company's president Barry Weiner. Enzo recently pocketed a multi-million dollar settlement from Affymetrix and Weiner expects the successful legal resolutions to continue without disrupting the ongoing business.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
RAD $ 5.41 1.23 ▼ 18.52%
BAC $ 17.04 0.27 ▲ 1.61%
YHOO $ 42.085 0.51 ▼ 1.19%
AAPL $ 101.79 0.21 ▲ 0.21%
MSFT $ 46.68 0.16 ▲ 0.34%
VVUS $ 4.36 0.48 ▲ 12.37%
GE $ 26.21 0.16 ▲ 0.61%
PBR $ 17.09 0.52 ▼ 2.95%

As of 9/18/2014, 04:15 PM
More Most Active

Latest News Headlines

View All